MedTrace Logo

Doxazosin and Ramipril in Hypertension

NCT02901977 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2025-03-04

No results posted yet for this study

Summary

Randomized double-blind parallel group study in patients with mild-to-moderate hypertension to evaluate the effects beyond the blood pressure lowering effect of treatment for 12 weeks with ramipril or doxazosin on hemostatic mechanisms and on endothelial function.

Conditions

Interventions

DRUG

Ramipril

Antihypertensive therapy

DRUG

Doxazosin

Antihypertensive therapy

Sponsors & Collaborators

Principal Investigators

  • Thomas Kahan, MD · Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2015-02-28
Completion
2015-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02901977 on ClinicalTrials.gov